1.
Nicolas Duployez, Guillaume Grzych, Benoît Ducourneau, Martin Alarcon Fuentes, Nathalie Grardel, Thomas Boyer, Wadih Abou Chahla, Bénédicte Bruno, Brigitte Nelken, Emmanuelle Clappier, Claude Preudhomme. NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors. haematol [Internet]. 2016Mar.31 [cited 2024Mar.28];101(4):e133-e134. Available from: https://haematologica.org/article/view/7690